Corporate Profile
Driven by years of leadership and innovation, Animal Cell Therapies, Inc. is at the forefront of a breakthrough approach to treating canine orthopedic conditions. They are applying their scientific and industry leadership in regenerative medicine to discover, develop and commercialize novel therapeutics, tools and technologies for use in stem cell-based research and discovery.
Letter to Investor
April 2012 Letter to Investors from CEO Adam Irving
January 2012 Letter to Investors from CEO Adam Irving
Request Investor Information
To request the Animal Cell Therapies Investor Information kit, please fill out the form below. Be sure to click ‘send’ when you are done.
